Top

Published in:

01-04-2007

Extrapleural Pneumonectomy Is the Preferred Surgical Management in the Multimodality Therapy of Pleural Mesothelioma: Con Argument

Author: Robert B. Cameron, MD

Published in: Annals of Surgical Oncology | Issue 4/2007

Excerpt

Malignant pleural mesothelioma (MPM) is an uncommon asbestos-related cancer with few good treatment options. Due to its low incidence/prevalence, frequent delay in diagnosis, and a strikingly short survival, few patients generally have been available for clinical trials. Because of a lack of therapeutic options, MPM historically has received little attention in many comprehensive cancer centers across the U.S. and throughout the world. In treatment centers that have specific programs for mesothelioma, treatment strategies often are remarkably different and based on considerable treatment biases. …

Maziak DE, Gagliardi A, Haynes AE, Mackay JA, Evans WK. Surgical management of malignant pleural mesothelioma: a systematic review and evidence summary. Lung Cancer 2005;48:157–69PubMedCrossRef

Meerbeeck JP, Boyer M. Consensus report: pretreatment minimal staging and treatment of potentially respectable malignant pleural mesothelioma. Lung Cancer 2005;49(Suppl 1):S123–7PubMedCrossRef

Aziz T, Jilaihawi A, Prakash D. The management of malignant pleural mesothelioma; single centre experience in 10 years. Eur J Cardiothorac Surg 2002;22(2):298–305PubMedCrossRef

Rusch VW, Rosenzweig K, Venkatraman E, Leon L, Raben A, Harrison L, Bains MS, Downey RJ, Ginsberg RJ. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2001;122(4):788–95PubMedCrossRef

Sugarbaker DJ, Jaklitsch MT, Bueno R, Richards W, Lukanich J, Mentzer SJ, Colson Y, Linden P, Chang M, Capalbo L, Oldread E, Neragi-Miandoab S, Swanson SJ, Zellos LS. Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg 2004;128(1):138–46PubMedCrossRef

Rusch VW, Venkatraman ES. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg 1999;68(5):1799–804PubMedCrossRef

Maggi G, Casadio C, Cianci R, Rena O, Ruffini E. Trimodality management of malignant pleural mesothelioma. Eur J Cardiothorac Surg 2001;19(3):346–50PubMedCrossRef

Calavrezos A, Koschel G, Husselmann H, Taylessani A, Heilmann HP, Fabel H, Schmoll HJ, Dietrich H, Hain E. Malignant mesothelioma of the pleura. A prospective therapeutic study of 132 patients from 1981–1985. Klin Wochenschr 1988;66(14):607–13PubMedCrossRef

Soysal O, Karaoglanoglu N, Demiracan S, Topcu S, Tastepe I, Kaya S, Unlu M, Cetin G. Pleurectomy/decortication for palliation in malignant pleural mesothelioma: results of surgery. Eur J Cardiothorac Surg 1997;11(2):210–3PubMedCrossRef

10.

Pass HI, Kranda K, Temeck BK, Feuerstein IR, Steinberg SM. Surgically debulked malignant pleural mesothelioma: results and prognostic factors. Ann Surg Oncol 1997;4(3):215–22PubMedCrossRef

11.

Jaklitsch MT, Grondin SC, Sugarbaker DJ. Treatment of malignant mesothelioma. World J Surg 2001;25(2):210–7PubMedCrossRef

12.

Boutin C, Rey F, Viallat JR. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest 1995;108:754–8PubMed

13.

Astoul P, Picat-Joossen D, Viallat JR, Boutin C. Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma: a phase II study. Cancer 1998;83(10):2099–104PubMedCrossRef

14.

Lee TT, Everett DL, Shu HK, Jahan TM, Roach M 3rd, Speight JL, Cameron RB, Phillips TL, Chan A, Jablons DM. Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2002;124(6):1183–9PubMedCrossRef

Title: Extrapleural Pneumonectomy Is the Preferred Surgical Management in the Multimodality Therapy of Pleural Mesothelioma: Con Argument
Author: Robert B. Cameron, MD
Publication date: 01-04-2007
Publisher: Springer-Verlag
Published in: Annals of Surgical Oncology / Issue 4/2007
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-006-9160-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Extrapleural Pneumonectomy Is the Preferred Surgical Management in the Multimodality Therapy of Pleural Mesothelioma: Con Argument

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2007

Treatment of the Adenocarcinoma of the Esophagogastric Junction at a Single Institution in Mexico

Combined Radioguided Nonpalpable Lesion Localization and Sentinel Lymph Node Biopsy for Early Breast Carcinoma

In Vivo Intraoperative Radiotherapy: A Novel Approach to Radiotherapy for Early Stage Breast Cancer

Low-dose Interleukin-2 Administered Pre-operatively to Patients with Gastric Cancer Activates Peripheral and Peritumoral Lymphocytes But Does Not Affect Prognosis

Anatomic Resection Independently Improves Long-Term Survival in Patients with T1–T2 Hepatocellular Carcinoma

Surgery as a Bridge to Palliative Chemotherapy in Patients with Malignant Bowel Obstruction from Colorectal Cancer